KRISTEN HINTE: Open Payments
NPI 1619422466 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 91 payments from 18 companies in 2025. Trend: 2023 $2,493 · 2024 $2,575 · 2025 $1,518
Food & beverage: $1,419Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $238 |
| UCB, Inc. | 12 | $222 |
| Regeneron Healthcare Solutions, Inc. | 6 | $159 |
| LEO Pharma Inc. | 8 | $144 |
| Galderma Laboratories, L.P. | 17 | $140 |
| Janssen Biotech, Inc. | 1 | $99 |
| Incyte Corporation | 3 | $74 |
| Lilly USA, LLC | 3 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $59 |
| Amgen Inc. | 2 | $50 |
Products named: Bimzelx, DUPIXENT, RINVOQ, ADBRY, TREMFYA, OPZELURA, SKYRIZI, NEMLUVIO.
Industry payments across IN — which companies pay providers there.
